Table 3.
Location | SL | HA-3h | HA-20h | |||
---|---|---|---|---|---|---|
Sample site | Radial arterial | Central venous | Radial arterial | Central venous | Radial arterial | Central venous |
TNF-α (pg ml−1) | 1.47 ± 1.54 | 1.35 ± 1.31 | 1.46 ± 1.23 | 1.38 ± 1.26 | 1.58 ± 1.24 | 1.40 ± 1.13* |
a-cvD (pg ml−1) | +0.12 ± 0.36 | +0.08 ± 0.17 | +0.18 ± 0.42 | |||
Exchange (pg min−1) | +0.48 ± 1.48 | +0.30 ± 0.69 | +0.64 ± 1.37 | |||
IL-6 (pg ml−1) | 0.50 ± 0.21 | 0.64 ± 0.38* | 1.82 ± 1.29† | 1.92 ± 1.23*† | 3.28 ± 2.91†‡ | 3.06 ± 1.61*†‡ |
a-cvD (pg ml−1) | −0.14 ± 0.23 | −0.10 ± 0.24 | +0.22 ± 2.61‡ | |||
Exchange (pg min−1) | −0.58 ± 1.00 | −0.36 ± 0.98 | +0.77 ± 8.62‡ |
TNF, tumour necrosis factor; IL, interleukin.
P < 0.05 vs. radial arterial for given location
P < 0.05 vs. SL for given sample site
P < 0.05 vs. HA-3h for given sample site.